Carbamazepine Treatment of Cocaine Dependence - 1 - Tabular View

Tracking Information

First Received Date ^ICMJE

September 20, 1999

Last Updated Date

November 3, 2005

Start Date ^ICMJE

October 1992

Primary Completion Date

Current Primary Outcome Measures ^ICMJE

Severity addiction
Amount of drug use
Affective stability
Medication compliance

Original Primary Outcome Measures ^ICMJE

Same as current

Change History

Complete list of historical versions of study NCT00000242 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Original Secondary Outcome Measures ^ICMJE

Descriptive Information

Brief Title ^ICMJE

Carbamazepine Treatment of Cocaine Dependence - 1

Official Title ^ICMJE

Carbamazepine Treatment of Cocaine Dependence

Brief Summary

The purpose of this study is to compare the efficacy of carbamazepine in treatment of cocaine-dependence in patients with affective disorders.

Detailed Description

Study Phase

Phase II

Study Type ^ICMJE

Interventional

Study Design ^ICMJE

Treatment

Condition ^ICMJE

Cocaine-Related Disorders
Substance-Related Disorders

Intervention ^ICMJE

Drug: Carbamazepine

Study Arms / Comparison Groups

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Completed

Enrollment ^ICMJE

Completion Date

Primary Completion Date

Eligibility Criteria ^ICMJE

Please contact site for information.

Gender

Both

Ages

18 Years to 65 Years

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

United States

Administrative Information

NCT ID ^ICMJE

NCT00000242

Responsible Party

Study ID Numbers ^ICMJE

NIDA-07761-1, R29-07761-1

Study Sponsor ^ICMJE

National Institute on Drug Abuse (NIDA)

Collaborators ^ICMJE

Medical University of South Carolina

Investigators ^ICMJE

Principal Investigator:

Kathleen Brady, Ph.D.

Medical University of South Carolina

Information Provided By

National Institute on Drug Abuse (NIDA)

Verification Date

July 1996

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP